NCT05035381 2021-09-05PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal CancerTianjin Medical University Cancer Institute and HospitalPhase 2 Unknown10 enrolled